Orient EuroPharma Co., Ltd. (TPEX:4120)

Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,435	1,736	1,801	1,959	2,121
Short-Term Investments	174.26	159.52	70.8	80.8	201.8
Cash & Short-Term Investments	1,609	1,896	1,872	2,040	2,323
Cash Growth	-15.10%	1.27%	-8.25%	-12.19%	26.68%
Accounts Receivable	847.2	783.01	730.48	580.03	524.06
Other Receivables	21.44	26.94	27.66	33.53	18.17
Receivables	868.64	809.94	758.15	613.55	542.23
Inventory	1,065	1,147	1,304	1,082	1,350
Prepaid Expenses	137.26	118.23	162.21	136.07	87.96
Other Current Assets	295.84	257.28	88.62	53.63	13.89
Total Current Assets	3,976	4,228	4,185	3,925	4,317
Property, Plant & Equipment	3,851	3,986	4,019	4,181	2,894
Long-Term Investments	2,296	1,064	533.57	416.83	191.06
Other Intangible Assets	43.76	42.69	43.01	78.16	104.48
Long-Term Deferred Tax Assets	623.1	677.16	588.05	631.87	522.46
Other Long-Term Assets	780.13	814.28	1,062	170.82	130.57
Total Assets	11,570	10,812	10,430	9,403	8,160
Accounts Payable	176.13	348.07	552.2	159.81	318.76
Accrued Expenses	296.94	274.85	353.04	390.66	456.17
Short-Term Debt	2,112	2,324	2,191	2,050	1,225
Current Portion of Long-Term Debt	379.89	272.31	350.18	246.82	158.57
Current Portion of Leases	38.79	41.95	44.06	25.78	32.41
Current Income Taxes Payable	20.21	138.39	16.02	55.52	13.76
Other Current Liabilities	283.6	312.65	286.42	303.12	224.54
Total Current Liabilities	3,308	3,712	3,793	3,232	2,429
Long-Term Debt	1,343	1,790	1,991	1,680	758.28
Long-Term Leases	354.37	412.89	447.92	218.46	229.47
Long-Term Deferred Tax Liabilities	670.13	651.99	671.26	728.29	746.01
Other Long-Term Liabilities	22.9	23.44	23.3	24.65	26.83
Total Liabilities	5,746	6,649	6,987	5,950	4,255
Common Stock	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	271.26	271.26	271.26	263.44	260.77
Retained Earnings	2,046	1,752	1,738	2,118	2,274
Comprehensive Income & Other	1,979	624.12	51.9	-307.04	-193.43
Total Common Equity	5,164	3,514	2,929	2,942	3,209
Minority Interest	660.39	648	514.77	511.39	696.34
Shareholders' Equity	5,824	4,162	3,444	3,453	3,905
Total Liabilities & Equity	11,570	10,812	10,430	9,403	8,160
Total Debt	4,229	4,841	5,024	4,221	2,403
Net Cash (Debt)	-2,620	-2,946	-3,153	-2,181	-80.19
Net Cash Per Share	-30.20	-33.88	-36.34	-25.08	-0.92
Filing Date Shares Outstanding	86.75	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.75	86.75	86.75	86.75	86.75
Working Capital	667.71	515.42	391.79	693.29	1,888
Book Value Per Share	59.53	40.51	33.76	33.91	36.99
Tangible Book Value	5,120	3,472	2,886	2,864	3,104
Tangible Book Value Per Share	59.03	40.02	33.27	33.01	35.78
Land	1,157	1,169	1,169	1,462	578.12
Buildings	2,300	2,347	2,243	2,190	1,754
Machinery	1,083	1,069	992.9	965.5	918.07
Construction In Progress	27.78	3.55	36.12	48.41	0.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.